Egress Capital Partners Inc.

FDA Regulatory Profile

Egress Capital Partners Inc. appears in FDA public data with 5 recalls, 0 510(k) clearances, 1 FDA inspection, and 0 compliance actions on record. Its most recent recall (H-0018-2026, Class II) was initiated on September 18, 2025.

Summary

Total Recalls
5
510(k) Clearances
0
Inspections
1
Compliance Actions
0

Recent Recalls

NumberClassProductDate
H-0018-2026Class IITaproom Gourmet brand 18lb bulk "Empire" MixSeptember 18, 2025
H-0016-2026Class IITaproom Gourmet brand 15lb bulk "Madison" MixSeptember 18, 2025
H-0015-2026Class IITaproom Gourmet brand 15lb bulk "Broadway" MixSeptember 18, 2025
H-0014-2026Class IITaproom Gourmet brand 20lb and 18lb bulk "Fifth Avenue" MixSeptember 18, 2025
H-0017-2026Class IITaproom Gourmet brand 20lb bulk "Park" MixSeptember 18, 2025